Point-of-care rapid tests for HIV antibodies

LaboratoriumsMedizin

Volumn 27, Issue 7-8, 2003, Pages 288-295

  Branson, B M ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Alternative confirmatory strategies; HIV antibody testing; Point of care testing; Rapid serological assays

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ANTIBODY DETECTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC KIT; EARLY DIAGNOSIS; ELECTROIMMUNOASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PERINATAL PERIOD; REVIEW; WESTERN BLOTTING;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2;

EID: 0041733197     PISSN: 03423026     EISSN: None     Source Type: Journal    
DOI: 10.1515/LabMed.2003.041     Document Type: Review

References (81)

1. Tu XM, Litvak E, Pagano M. Issues in human immunodeficiency virus (HIV) screening programs. Am J Epidemiol 1993;136: 244-55.
2. Public Health Service guidelines for counseling and antibody testing to prevent HIV infection and AIDS. MMWR Morb Mortal Wkly Rep 1987;36:509-15.
3. Interpretation and use of the Western blot assay for serodiagnosis of human immunodeficiency virus type 1 infections. MMWR Morb Mortal Wkly Rep 1989;38(No. S-7):1-7.
4. Branson BM. Assessing diagnostic technologies marketed to less industrialized countries. Journal of International Association of Physicians in AIDS Care 2000; February:28-30.
5. Constantine, NT. Serological tests for retroviruses: approaching a decade of evolution. AIDS 1993;7:1-13.
6. Stetler HC, Granade TC, Nunez CA, Meza R, Terrell S, Amador L, George JR. Field evaluation of rapid HIV serologic tests for screening and confirming HIV-1 infection in Honduras. AIDS 1997; 11:369-75.
7. Wilkinson D, Habgood LC. The evolving HIV epidemic in a rural hospital in Zululand from 1989 to 1993. Epidemiol Comments 1994;21:9-13.
8. Valdiserri RO, Moore M, Gerber AR, Campbell CH, Dillon BA, West GR. A study of clients returning for counseling after HIV testing: implications for improving rates of return. Public Health Rep 1993;109:12-18.
9. Wiley DJ, Frerichs RR, Ford WL, Simon PA. Failure to learn human immunodeficiency virus test results in Los Angeles public sexually transmitted disease clinics. Sex Transm Dis 1998;25:342-5.
10. Tao G, Branson BM, Kassler WJ, Cohen RA. Rates of receiving HIV test results: Data from the U.S. National Health interview Survey for 1994 and 1995. J Acquir Immune Defic Syndr 1999;22:395-400.
11. Kassler WJ, Dillon BA, Haley C, Jones WK, Goldman A. Onsite, rapid HIV testing with same-day results and counseling. AIDS 1997;11:1045-51.
12. Wilkinson D, Wilkinson N, Lombard C, Martin D, Smith A, Floyd K, Ballard R. On-site HIV testing in resource-poor settings: Is one rapid test enough? AIDS 1997;11:377-81.
13. Malonza IM, Richardson BA, Kreiss JK, Bwayo JJ, John Stewart GC. The effect of rapid HIV-1 testing on uptake of perinatal HIV-1 interventions: a randomized clinical trial. AIDS 2003; 17:113-8.
14. Squire SB, Elford J, Bor R, Tilsed G, Salt H, Bagdades EK, Janossy G, Griffiths PD, Johnson MA. Open access clinic providing HIV-I antibody results on day of testing: the first twelve months. BMJ 1991;302:1383-6.
15. Ronald CJ, Nelson WI, Jeffries DJ. Same-day testing for HIV. PHLS Microbiol Digest 1993;10:20-22.
16. Morris DJ, Corbitt G, Crosdale E. Same-day testing for human immunodeficiency virus antibodies. J Virol Methods 1994;49:367-70.
17. Kassler WJ, Alwano-Edyegu MG, Marum E, Biryahwaho B, Kataaha P, Dillon B. Rapid HIV testing with same-day results: A field trial in Uganda. Int J STD AIDS 1998;9:134-8.
18. Keenan PA, Keenan JM. Rapid HIV testing in urban outreach: a strategy for improving posttest counseling rates. AIDS Educ Prev 2001;13:541-50.
19. Kelen GD, Shahan JB, Quinn TC. Emergency department-based HIV screening and counseling: Experience with rapid and standard serologic testing. Ann Emerg Med 1999;33:147-54.
20. Quinn TC, Riggin CH, Kline RL, Francis H, Mulanga K, Sension MG, Fauci AS. Rapid latex agglutination assay using recombinant envelope polypeptide for the detection of antibody to the HIV. JAMA 1988;260:510-3.
21. Riggin CH, Beltz GA, Hung CH, Thorn RM, Marciani DJ. Detection of antibodies to human immunodeficiency virus by latex agglutination with recombinant antigen. J Clin Microbiol 1987;25: 1772-3.
22. Constantine NT, Fox E, Abbatte EA, Woody JN. Diagnostic usefulness of five screening assays for HIV in an east African city where prevalence of infection is low. AIDS 1989;3:313-7.
23. Spielberg F, Kabeya CM, Ryder RW, Kifuani NK, Harris J, Bender TR, Heyward WL, Quinn TC. Field testing and comparative evaluation of rapid, visually read screening assays for antibody to human immunodeficiency virus. Lancet 1989; i:580-4.
24. Van kerckhoven I, Vercauteren G, Piot P, van der Groen G. Comparative evaluation of 36 commercial assays for detecting antibodies to HIV. Bull World Health Organ 1991;69:753-60.
25. Mitchell SW, Mboup S, Mingle J, Sambe D, Tukei P, Milenge K, Nyamongo J, Mubarak OK, Sankala JL, Hanson DS, Quinn TC. Field evaluation of alternative HIV testing strategy with a rapid immunobinding assay and an agglutination assay. Lancet 1991;337: 1328-30.
26. Malone JD, Smith ES, Sheffield J, Bigelow D, Hyams KC, Beardsley SG, Lewis RS, Roberts CR. Comparative evaluation of six rapid serological tests for HIV-1 antibody. J Acquir Immune Defic Syndr 1993;6:115-9.
27. Giles RE, Perry KR, Parry JV. Simle/rapid test devices for anti-HIV screening: Do they come up to the mark? J Virol Methods 1999;59:104-9.
28. Meda N, Gautier-Charpentier L, Soudre RB, Dahourou H, Ouedraogo-Traore R, Ouangre A, Bambara A, Kpozehouen A, Sanou H, Valea D, Ky F, Caroux M, Barin F, Van de Perre P. Serological diagnosis of human immunodeficiency virus in Burkina Faso: reliable, practical strategies using less expensive commercial test kits. Bull World Health Organ 1999;77:731-9.
29. Kannangai R, Ramalingam S, Pradeepkumar S, Dahmodharan K, Sridharan G. Hospital-based evaluation of two rapid human immunodeficiency virus antibody screening tests. J Clin Microbiol 2000;38:3445-7.
30. Lien TX, Tien NTK, Chanpong GF, Cuc CT, Yen VT, Soderquist R, Lras K, Corwin A. Evaluation of rapid diagnostic tests for the detection of human immunodeficiency virus types 1 and 2, hepatitis B surface antigen, and syphilis in Ho Chi Minh City, Vietnam. Am J Trop Med Hyg 2000;62:301-9.
31. McKenna SL, Muyinda GK, Roth D, Mwali M, Ng'andu N, Myrick A, Luo C, Priddy FH, Hall VM, von Lieven AA, Sabatino JR, Mark K, Allen SA. Rapid HIV testing and counseling for voluntary testing centers in Africa. AIDS 1997; 11(suppl1):S103-S110.
32. Urassa WK, Bredberg-Raden U, Mbena E, Palsson K, Minja E, Lema RA, Pallangyo K, Mhalu FS, Biberfeld G. Alternative confirmatory strategies in HIV-1 antibody testing. J Acquir Immune Defic Syndr 1992;5:170-6.
33. Brattegaard K, Kouadio J, Adom ML, Doorly R, George JR, De Cock KM. Rapid and simple screening and supplemental testing for HIV-1 and HIV-2 infections in west Africa. AIDS 1993;7:883-5.
34. Downing RG, Otten RA, Marum E. Optimizing the delivery of HIV counseling and testing services: The Uganda experience using rapid HIV antibody test algorithms. J Acquir Immune Defic Syndr 1998;18:384-8.
35. Koblavi Demi S, Maurice C, Yavo D, Sibailly TS, N'Gussan K, Kamelan-Tamo Y, Wiktor SZ, Roels TH, Chorba T, Nkengasong JN. Sensitivity and specificity of human immunodeficiency virus rapid serologic assays and testing algorithms in an antenatal clinic in Abidjan, ivory Coast. J Clin Micro 2001;39:1808-12.
36. Urassa W, Nozohoor S, Jaffer S, Karama K, Mhalu F, Biberfeld G. Evaluation of an alternative confirmatory strategy for the diagnosis of HIV infection in Dar Es Salaam, Tanzania, based on simple rapid assays. J Virol Methods 2002; 100: 115-120.
37. Global Programme on AIDS. Recommendations for the selection and use of HIV antibody tests. Wkly Epidemiol Rec 1992;67:145-9.
38. Joint United Nations Programme on HIV/AIDS (UNAIDS). Revised recommendations for the selection and use of HIV antibody tests. Wkly Epidemiol Rec 1997;72:81-88.
39. Joint United Nations Progamme on HIV/AIDS. The importance of simple/ rapid assays in HIV testing. Wkly Epidemiol Rec 1998; 73:321-8.
40. Spielberg F, Branson B, Goldbaum G, Kurth A. Overcoming barriers to HIV testing: preferences for new strategies among clients of a needle exchange, a sexually transmitted disease clinic and sex venues for MSM. J Acquir Immune Defic Syndr 2003;32:318-27.
41. Centers for Disease Control and Prevention. Update: HIV counseling and testing using rapid tests(United States, 1995. MMWR Morb Mortal Wkly Rep 1998;47:211-5.
42. Schramm W, Wade SE, Barriga Angulo G, Castillo Torres P, Burgess-Cassler A. A simple whole-blood test for detecting antibodies to human immunodeficiency virus. Clin Diagn Lab Immunol 1998;5:263-5.
43. Arai H, Petchclai B, Khupulsup K, Kurimura T, Takeda K. Evaluation of a rapid immunochromatographic test for detection of antibodies to human immunodeficiency virus. J Clin Mirobiol 1999;37: 367-70.
44. Palmer CJ, Dubon JM, Koenig E, Perez E, Ager A, Jayaweera D, Cuadrado RR, Rivera A, Rubido A, Palmer DA. Field evaluation of the Determine rapid human immunodeficiency virus diagnostic test in Honduras and the Dominican Republic. J Clin Microbiol 1999;37:3698-3700.
45. Shafran SD, Conway B, Prasad E, Greer J, Vincelette J, Ellis CE, Haase DA, Walmsley SL, Lalonde RG, Cameron DW. Field evaluation of the Merlin immediate HIV-1 and -2 test for point-of-care detection of human immunodeficiency virus antibodies. Clin Infect Dis 2002;34:658-61.
46. Centers for Disease Control and Prevention. Notice to readers: approval of a new rapid test for HIV antibody. Morb Mortal Wkly Rep 2002;51:1051.
47. Operational characteristics of commercially available assays to determine antibodies to HIV-1 and/or HIV-2 in human sera. Geneva, Switzerland: United Nations Programme on AIDS and World Health Organization. Reports 1-11, 1993-1999.
48. Constantine NT, Zekeng L, Sangare AK, Gurtler L, Saville R, Anhary H, Wild C. Diagnostic challenges for rapid human immunodeficiency virus assays: Performance using HIV-1 group O, HIV-1 group M, and HIV-2 samples. J Human Virol 1997;1:45-51.
49. Phillips S, Granade TC, Pau CP, Candal D, Hu DJ, Parekh BS. Diagnosis of human immunodeficiency virus type 1 infection with different subtypes using rapid tests. Clin Diag Lab Immunol 2000;7: 698-9.
50. Makuwa M, Souquiere S, Niangui MT, Rouquet P, Apetrei C, Roques P, Simon F. Reliability of rapid diagnostic tests for HIV variant infection. J Virol Methods 2002;103:183-90.
51. Reynolds SJ, Ndongala LM, Luo CC, Mwandagalirwa K, Losoma AJ, Mwamba KJ, Bazepeyo E, Nzilambi NE, Quinn TC, Bollinger RC. Evaluation of a rapid test for the detection of antibodies to human immunodeficiency virus type I and 2 in the setting of multiple transmitted viral subtypes. Int J STD AIDS 2002;13:171-3.
52. Branson B, Meredith N, Mei J, Hannon H. How well do rapid HIV tests detect seroconverters? [abstract]. In: Program and Abstracts, 9th Conference on Retroviruses and Opportunistic Infections, Seattle, Washington: Foundation for Retrovirology and Human Health, 2002.
53. Starkey CA, Yen-Lieberman B, Proffitt MR. Evaluation of the Recombigen HIV-1 latex agglutination test. J Clin Microbiol 1990; 28:819-22.
54. Health Canada. Point of Care HIV testing using simple/rapid HIV test kits: guidance for health-care professionals. Canada Communicable Disease Report 2000;26:49-59.
55. Branson B, Uniyal A, Fridlund C, Granade T, Kerndt P. Performance of newer rapid tests for HIV antibody with whole blood and plasma [abstract]. In: Program and Abstracts, 9th Conference on Retroviruses and Opportunistic Infections, Seattle, Washington: Foundation for Retrovirology and Human Health, 2002.
56. HIV simple/rapid assays: Operational characteristics (Phase I) whole blood specimens. Geneva, Switzerland: United Nations Programme on AIDS and World Health Organization. Report 12 (draft), 2002.
57. Dax EM, O'Connell R. Standardisation of subjectively scored HIV immunoassays developing a quality assurance program, to assist in reproducible interpretation of results using an anti-IV particle agglutination assay as a model. J Virol Methods 1999;82:113-8.
58. Guidelines for using HIV testing technologies in surveillance: Selection, evaluation, and implementation. Atlanta, Georgia: World Health Organization and Joint United Nations Programme on HIV/AIDS. Document 01.22E, 2001.
59. Albritton WL, Vittinghoff E, Padian NS. Human immunodeficiency virus testing for patient-based and population-based diagnosis. J Infect Dis 1996; 174(suppl 2):S176-81.
60. th International AIDS Conference, Barcelona, Spain, 2002.
61. th International AIDS Conference, Barcelona, Spain, 2002.
62. Wade NA, Birkhead GS, Warren BL, Charbonneau TT, French PT, Wang L, Baum JB, Tesoriero JM, Savicki R. Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus. N Engl J Med 1998;339:1409-14.
63. Kourtis AP, Bulterys M, Nesheim SR, Lee FK. Understanding the timing of HIV transmission from mother to infant. JAMA 2001; 285:709-12.
64. Webber MP, Demas P, Enriquez E, Shanker R, Oleszko W, Beatrice ST, Schoenbaum EE. Pilot study of expedited HIV-1 testing of women in labor at an inner-city hospital in New York City. Am J Perinatol 2001;18:49-57.
65. Chalermchockcharoenkit A, Louisirirotchnakul S, Roongpisuthipong A, Sirimai K, Suctchritpongsa P, Wasi C. Rapid human immunodeficiency virus diagnostic test during the intrapartum period in pregnant women who did not receive antenatal care. J Med Assoc Thai 2002;85:703-8.
66. Nogueira SA, Lambert JS, Albuquerque AL, Rodrigues R, Reis S, Bomia R, Dias M, Barbosa R, Sztanjbock D, Santos AL, Blattner W, Constantine NT. Assessment of a rapid HIV test strategy during labor: a pilot study from Rio de Janeiro, Brazil. J Hum Virol 2001;4: 278-82.
67. Grobman WA, Garcia PM. The cost-effectiveness of voluntary intrapartum rapid human immunodeficiency virus testing for women without adequate prenatal care. Am J Obstet Gynecol 1999;181: 1062-71.
68. Stringer JS, Rouse DJ. Rapid testing and zidovudine treatment to prevent vertical transmission of human immunodeficiency virus in unregistered parturients: a cost-effectiveness analysis. Obstet Gynecol 1999;94:34-40.
69. th Conference on Retroviruses and Opportunistic Infections, Boston, Massachusetts: Foundation for Retrovirology and Human Health, 2003.
70. Centers for Disease Control and Prevention. Case-control study of HIV seroconversion in health-care workers after percutaneous exposure to HIV-infected blood (France, United Kingdom and United States, January 1988 - August 1994. MMWR Morb Mortal Wkly Rep 1995;44:929-33.
71. Machado AA, Martinez R, Haikal AA, Rodrigues da Silva MC. Advantages of the rapid HIV-1 test in occupational accidents with potentially contaminated material among health workers. Rev Inst Med Trop Sao Paulo 2001;43:199-201.
72. Kallenborn JC, Price TG, Carrico R, Davidson AB. Emergency department management of occupational exposures: cost analysis of rapid HIV test. Infect Control Hosp Epidemiol 2001;22:289-93.
73. Clark SJ, Kelen GD, Henrard DR, Daar ES, Craig S, Shaw GM, Quinn TC. Unsuspected primary human immunodeficiency virus type 1 infection in seronegative emergency department patients. J Infect Dis 1994;170:194-7.
74. Irwin K, Olivo N, Schable CA, Weber JT, Janssen R, Ernst J. Performance characteristics of a rapid HIV antibody assay in a hospital with a high prevalence of HIV infection. Ann Intern Med 1996; 125:471-5.
75. Centers for Disease Control and Prevention. Routinely Recommended HIV Testing at an Urban Urgent-Care Clinic - Atlanta, Georgia, 2000. MMWR Morb Mortal Wkly Rep 2001;50:538-41.
76. Cleary PD, Van Devanter N, Rogers TF, E, Shipton-Levy R, Steilen M, Stuart A, Avorn J, Pindyck J. Behavior changes after notification of HIV infection. Am J Public Health 1991;81:1586-90.
77. Otten MW, Zaidi AA, Wroten JE, Witte JJ, Peterman TA. Changes in sexually transmitted disease rates after HIV testing and posttest counseling, Miami, 1988 to 1989. Am J Public Health 1993; 83:529-33.
78. Colfax GN, Buchbinder SP, Cornelisse PG, Vittinghoff E, Mayer K, Celum C. Sexual risk behaviors and implications for secondary HIV transmission during and after HIV seroconversion. AIDS 2002; 16:1529-35.
79. Wiktor SJ, Biggar RJ, Melgye M, Ebbesen P, Colclough G, Di Gioia R, Sanchez WC, Grossman RJ, Goedert JJ. Effect of knowledge of human immunodeficiency virus infection status on sexual activity among homosexual men. J Acquir Immune Defic Syndr 1990;3:62-8.
80. Dawson JM, Fitzpatrick RM, Reeves G, Boulton M, McLean J, Hart GJ, Brookes M. Awareness of sexual partners' HIV status as an influence upon high-risk sexual behaviour among gay men. AIDS 1994;8:837-41.
81. Varghese B, Maher JE, Peterman TA, Branson BM, Steketee RW. Reducing the risk of sexual HIV transmission: quantifying the per-act risk for HIV on the basis of choice of partner, sex act, and condom use. Sex Transm Dis 2002;29:38-43.